These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12565780)

  • 1. Osteocalcin gene HindIII C/T polymorphism is a biomarker for prostate cancer and responsiveness to hormone therapy.
    Wu HC; Lin CC; Chen WC; Chen HY; Tsai FJ
    Eur Urol; 2003 Feb; 43(2):197-200. PubMed ID: 12565780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteocalcin gene Hind III polymorphism is not correlated with calcium oxalate stone disease.
    Chen WC; Chen HY; Wu JY; Chen YT; Tsai FJ
    Urol Res; 2001 Apr; 29(2):98-101. PubMed ID: 11396736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for prostate cancer.
    Lin CC; Wu HC; Tsai FJ; Chen HY; Chen WC
    Urology; 2003 Aug; 62(2):374-7. PubMed ID: 12893367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel polymorphism in the promoter region for the human osteocalcin gene: the possibility of a correlation with bone mineral density in postmenopausal Japanese women.
    Dohi Y; Iki M; Ohgushi H; Gojo S; Tabata S; Kajita E; Nishino H; Yonemasu K
    J Bone Miner Res; 1998 Oct; 13(10):1633-9. PubMed ID: 9783552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum undercarboxylated osteocalcin as biomarker of vitamin K intake and risk of prostate cancer: a nested case-control study in the Heidelberg cohort of the European prospective investigation into cancer and nutrition.
    Nimptsch K; Rohrmann S; Nieters A; Linseisen J
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):49-56. PubMed ID: 19124480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-cadherin gene 3'-UTR C/T polymorphism is associated with prostate cancer.
    Wu HC; Lai MT; Wu CI; Chen HY; Wan L; Tsai FJ; Chen WC
    Urol Int; 2005; 75(4):350-3. PubMed ID: 16327305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteocalcin HindIII gene polymorphism not associated with bone mineral density—A study in North Indian postmenopausal osteoporotic women.
    Ahmad I; Jafar T; Mahdi F; Arshad MD; Das SK; Waliullah S; Rizvi I; Mahdi AA
    Indian J Exp Biol; 2016 Nov; 54(11):788-93. PubMed ID: 30179426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP17 gene polymorphism and prostate cancer susceptibility in a Tunisian population.
    Souiden Y; Mahdouani M; Chaieb K; Elkamel R; Mahdouani K
    Cancer Epidemiol; 2011 Oct; 35(5):480-4. PubMed ID: 21193363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 gene codon 72 polymorphism but not tumor necrosis factor-alpha gene is associated with prostate cancer.
    Wu HC; Chang CH; Chen HY; Tsai FJ; Tsai JJ; Chen WC
    Urol Int; 2004; 73(1):41-6. PubMed ID: 15263792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.
    Navone NM; Troncoso P; Pisters LL; Goodrow TL; Palmer JL; Nichols WW; von Eschenbach AC; Conti CJ
    J Natl Cancer Inst; 1993 Oct; 85(20):1657-69. PubMed ID: 7692074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A polymorphism in the CYP17 gene is associated with prostate cancer risk.
    Gsur A; Bernhofer G; Hinteregger S; Haidinger G; Schatzl G; Madersbacher S; Marberger M; Vutuc C; Micksche M
    Int J Cancer; 2000 Aug; 87(3):434-7. PubMed ID: 10897051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of lipoprotein lipase gene polymorphism with risk of prostate cancer in a Japanese population.
    Narita S; Tsuchiya N; Wang L; Matsuura S; Ohyama C; Satoh S; Sato K; Ogawa O; Habuchi T; Kato T
    Int J Cancer; 2004 Dec; 112(5):872-6. PubMed ID: 15386377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARE-I polymorphism on PSA gene in prostate cancer patients of a Turkish population.
    Kalay E; Ergen A; Narter F; Agaçhan B; Görmüs U; Yigit N; Isbir T
    Anticancer Res; 2009 Apr; 29(4):1395-8. PubMed ID: 19414393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association between genetic polymorphism of erythrocyte CR1 and the susceptibility of idiopathic pulmonary fibrosis].
    Yuan YD; Zhao MX; Yu J
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Nov; 34(11):841-5. PubMed ID: 22333472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A G/A polymorphism in the androgen response element 1 of prostate-specific antigen gene correlates with the response to androgen deprivation therapy in Japanese population.
    Shibahara T; Onishi T; Franco OE; Arima K; Nishikawa K; Yanagawa M; Hioki T; Watanabe M; Hirokawa Y; Shiraishi T; Sugimura Y
    Anticancer Res; 2006; 26(5A):3365-71. PubMed ID: 17094454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human glutathione S-transferase polymorphisms associated with prostate cancer in the Brazilian population.
    Så RA; Moreira Ados S; Cabello PH; Ornellas AA; Costa EB; Matos Cda S; Alves G; Hatagima A
    Int Braz J Urol; 2014; 40(4):463-73. PubMed ID: 25251951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Fok1 vitamin D receptor gene polymorphism and 25(OH) D serum levels and prostate cancer among Jordanian men.
    Atoum MF; AlKateeb D; AlHaj Mahmoud SA
    Asian Pac J Cancer Prev; 2015; 16(6):2227-30. PubMed ID: 25824742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D receptor polymorphisms and lethal prostate cancer.
    Kibel AS; Isaacs SD; Isaacs WB; Bova GS
    J Urol; 1998 Oct; 160(4):1405-9. PubMed ID: 9751364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the T-786C, G894T, and Intron 4 VNTR (4a/b) polymorphisms of the endothelial nitric oxide synthase gene on the risk of prostate cancer.
    Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
    Urol Oncol; 2013 Oct; 31(7):1132-40. PubMed ID: 22317880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate cancer.
    Dos Reis ST; Pontes J; Villanova FE; Borra PM; Antunes AA; Dall'oglio MF; Srougi M; Leite KR
    J Urol; 2009 May; 181(5):2320-5. PubMed ID: 19303106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.